Industrials · Specialty Business Services · NYSE · United States
$54.94+0.09%
Market cap $3.0BNext earnings 2026-10-19Updated Oct 23, 2026
Our verdict
Trades 9% above our fair value
Price
$54.94
Model fair valueConfidence: good
$50.37
Model range
$24.02 to $89.56
Fair value $50.37
Price $54.94
3 models fit CBIZ Inc. Common Stock and they disagree: 0 of 3 land within 15% of the average.
Two or more of our models back this value.
Near fair value(i)Silver69
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionCBIZ Inc. Common Stock (CBZ)
Fair value (3 models)
$50.37
ACCE price target
$59.50
Rating
Fairly valued
Horizon
12 months
Fair value published on 23 Oct 2026, 11:04 CEST; previously $54.89 since 14 Oct 2026, 00:00 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST; previously $62.00 since 11 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 16:04 CEST.
Price used: $54.94 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
9.1% above
-8.3% to fair value
ACCE score
51
out of 100
Analysts
0% buy
3 covering
P/E
23.1x
forward 12.3x
1-year return
+3.3%
Dividend yield
0.00%
CBIZ Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
CBIZ sells accounting, tax, and benefits services to small and mid-sized businesses in the US, with its CBIZ Benefits & Insurance and Financial Services segments being the core revenue engines. The business rests on recurring advisory relationships and the cross-selling that comes from serving the same client across payroll, tax, and insurance, which gives it a sticky customer base but a thin gross margin of 15.2% and an operating margin of 5.0%. Revenue is flat to slightly down (-0.2% growth), so the investment case depends on margin recovery and earnings growth rather than top-line expansion. The stock trades at 26.4 times trailing earnings but only 12.9 times forward earnings, a gap that signals the market expects a sharp rebound in profitability, and that expectation is the thing to test first. With a 6.5% return on equity and a score of 50/100, the name is a candidate for a deeper look at whether the forward estimates are credible rather than a conclusion in itself.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Earnings collapsing despite stable revenue
Earnings are down 53.0% year on year while revenue slipped only 0.2%, and the QoQ move is -19.6%. Operating margin of 5.0% points to thin cushion for further compression.
moderate
Leverage elevated for the earnings trend
Debt to equity is 1.04 with ROE at just 6.5%, so the balance sheet is carrying meaningful debt against weakening profit generation.
moderate
Score down sharply in 90 days
The ACCE score fell 9 points from 59 to 50 over 90 days, with quality at 43, suggesting deteriorating fundamentals rather than a one-off dip.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Free cash flow over the last twelve months reached $176M, a cash return of 5.8% at the current share price.
Latest quarterly earnings beat expectations, reporting $0.91 per share against $0.73 expected, a 24.7% surprise.
On forward earnings the stock trades at 12.2x, well below the sector median of 23.6x.
Why it could disappoint
Revenue growth was -0.2% year over year, against a five-year average of +23.4% per year, so the growth engine has stalled.
Returns are thin, with return on invested capital at 2.6% and return on equity at 6.5%, both weak for the capital tied up.
The diluted share count rose 20.1% last fiscal year, diluting each shareholder's slice of future earnings and cash.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where CBZ's valuation models land
Price
$54.94
Model fair value
$50.37
Model range
$24.02 to $89.56
Fair value $50.37
Price $54.94
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores